1. Home
  2. NVEE vs SRPT Comparison

NVEE vs SRPT Comparison

Compare NVEE & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEE
  • SRPT
  • Stock Information
  • Founded
  • NVEE 1949
  • SRPT 1980
  • Country
  • NVEE United States
  • SRPT United States
  • Employees
  • NVEE N/A
  • SRPT N/A
  • Industry
  • NVEE Other Consumer Services
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVEE Consumer Discretionary
  • SRPT Health Care
  • Exchange
  • NVEE Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • NVEE 1.5B
  • SRPT 1.7B
  • IPO Year
  • NVEE 2013
  • SRPT 1997
  • Fundamental
  • Price
  • NVEE $22.89
  • SRPT $17.29
  • Analyst Decision
  • NVEE Buy
  • SRPT Hold
  • Analyst Count
  • NVEE 4
  • SRPT 29
  • Target Price
  • NVEE $26.50
  • SRPT $46.46
  • AVG Volume (30 Days)
  • NVEE 946.0K
  • SRPT 19.6M
  • Earning Date
  • NVEE 08-06-2025
  • SRPT 08-11-2025
  • Dividend Yield
  • NVEE N/A
  • SRPT N/A
  • EPS Growth
  • NVEE N/A
  • SRPT N/A
  • EPS
  • NVEE 0.45
  • SRPT N/A
  • Revenue
  • NVEE $962,752,000.00
  • SRPT $2,233,371,000.00
  • Revenue This Year
  • NVEE $11.23
  • SRPT $3.52
  • Revenue Next Year
  • NVEE $5.16
  • SRPT N/A
  • P/E Ratio
  • NVEE $49.71
  • SRPT N/A
  • Revenue Growth
  • NVEE 8.74
  • SRPT 59.15
  • 52 Week Low
  • NVEE $14.75
  • SRPT $10.42
  • 52 Week High
  • NVEE $26.14
  • SRPT $146.38
  • Technical
  • Relative Strength Index (RSI)
  • NVEE 50.17
  • SRPT 45.11
  • Support Level
  • NVEE $21.77
  • SRPT $10.42
  • Resistance Level
  • NVEE $23.35
  • SRPT $19.24
  • Average True Range (ATR)
  • NVEE 0.43
  • SRPT 2.15
  • MACD
  • NVEE -0.11
  • SRPT 0.81
  • Stochastic Oscillator
  • NVEE 59.76
  • SRPT 53.05

About NVEE NV5 Global Inc.

NV5 Global Inc is a provider of technology, conformity assessment, and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, environmental, and geospatial markets, operating nationwide and abroad. The Company's clients include the U.S. Federal, state and local governments, and the private sector. It also serve quasi-public and private sector clients from the education, healthcare, utility services, and public utilities, including schools, universities, hospitals, health care providers, and insurance providers. The operating business segments are Infrastructure, Building, Technology & Sciences, and Geospatial Solutions. The maximum revenue derives from the infrastructure segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: